Lundbeck's former head of North America appointed CEO of Capsida Biotherapeutics

Lundbeck's departing head of North America, Peter Anastasiou, now reveals his new job title in a post on social media LinkedIn.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck's CEO: Departing CFO is not defecting to competitor
For subscribers
Lundbeck's chief financial officer to exit before May 2022
For subscribers
Lundbeck appoints new chief commercial officer
For subscribers